BIIB Articles and Guides
TickerPosts guides and articles tagged BIIB. Plain-English, calm, and written for everyday investors. 1 post.
Biogen (BIIB) Stock News: JPMorgan Upgrades to Overweight on 2027 Trial Readouts
JPMorgan upgraded Biogen to Overweight with a $300 target, up from $210, pointing to three clinical readouts by 2027 led by felzartamab in transplant rejection.
· 1 min read